Drug Database
Back to search

Switzerland· 34735034

Otipax, liquido

A lidocaine product containing phenazonum, lidocaini hydrochloridum monohydricum, registered in Switzerland by Zambon Svizzera SA and dispensed under Swissmedic category D. The same ATC class is registered in 4 of our 19 countries.

Cat D (Swissmedic)ATC S02DA01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedOtipax, liquidoATCS02DA01REGISTER NO.34735034PACKS LISTED0CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about phenazonum, lidocaini hydrochloridum monohydricumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lidocaine is registered in 4 of 19 countries.

Countries holding a registration under ATC S02DA01 (lidocaine), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 3 of them publish a price we can compare per daily dose
Search lidocaine products by name

Lidocaine · ATC S02DA01

4 / 19 countries

  • Belgiumprice
  • Netherlands
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
phenazonum, lidocaini hydrochloridum monohydricum
Manufacturer
Zambon Svizzera SA
Country
Switzerland (CH)
ATC code
S02DA01
ATC class
Lidocaine
Swissmedic category
D
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lidocaine in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lidocaine products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Bulgaria · Otipax, Дроплекс
  • Czechia · Otipax
  • Estonia · Finoten
  • France · Otipax
  • United Kingdom (Northern Ireland) · Otigo
  • Hungary · Otipax
  • Lithuania · Finoten, Otipax
  • Luxembourg · Otipax
  • Latvia · Finoten, Otipax
  • Malta · Otipax
  • Romania · Otilerin, Otipax

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e1e4bcf4-b81d-4784-a118-37e061f6775d
GET /v1/drugs/e1e4bcf4-b81d-4784-a118-37e061f6775d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}
API referenceMCP serverPlans

See everything about lidocaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console